Eve Elizabeth Slater - Net Worth and Insider Trading
Eve Elizabeth Slater Net Worth
The estimated net worth of Eve Elizabeth Slater is at least $528,068 dollars as of 2024-09-20. Eve Elizabeth Slater is the Director of Vertex Pharmaceuticals Inc and owns about 1,105 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $528,068. Details can be seen in Eve Elizabeth Slater's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eve Elizabeth Slater has not made any transactions after 2007-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eve Elizabeth Slater
Eve Elizabeth Slater Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eve Elizabeth Slater owns 3 companies in total, including Aceragen Inc (ACGN) , Vertex Pharmaceuticals Inc (VRTX) , and Innoviva Inc (INVA) .
Click here to see the complete history of Eve Elizabeth Slater’s form 4 insider trades.
Insider Ownership Summary of Eve Elizabeth Slater
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACGN | Aceragen Inc | 2010-06-16 | director |
| VRTX | Vertex Pharmaceuticals Inc | 2007-05-29 | director |
| INVA | Innoviva Inc | 2005-12-08 | director |
Eve Elizabeth Slater Latest Holdings Summary
Eve Elizabeth Slater currently owns a total of 1 stock. Eve Elizabeth Slater owns 1,105 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 29, 2007, with a value of $528,068.
Latest Holdings of Eve Elizabeth Slater
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2007-05-29 | 1,105 | 477.89 | 528,068 |
Holding Weightings of Eve Elizabeth Slater
Eve Elizabeth Slater Form 4 Trading Tracker
According to the SEC Form 4 filings, Eve Elizabeth Slater has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 10,000 shares on May 29, 2007, which brought Eve Elizabeth Slater around $304,200.
Insider Trading History of Eve Elizabeth Slater
- 1
Eve Elizabeth Slater Trading Performance
GuruFocus tracks the stock performance after each of Eve Elizabeth Slater's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eve Elizabeth Slater is -3.39%. GuruFocus also compares Eve Elizabeth Slater's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eve Elizabeth Slater within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eve Elizabeth Slater's insider trading performs compared to the benchmark.
Performance of Eve Elizabeth Slater
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.6 | | | | | |
| Relative Return to S&P 500(%) | 7.97 | | | | | |
Eve Elizabeth Slater Ownership Network
Eve Elizabeth Slater Owned Company Details
What does Aceragen Inc do?
Who are the key executives at Aceragen Inc?
Eve Elizabeth Slater is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .
Aceragen Inc (ACGN) Insider Trades Summary
Over the past 18 months, Eve Elizabeth Slater made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .
In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.
Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aceragen Inc Insider Transactions
Eve Elizabeth Slater Mailing Address
Above is the net worth, insider trading, and ownership report for Eve Elizabeth Slater. You might contact Eve Elizabeth Slater via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Attn: General Counse, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
